In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2. (2021)
Attributed to:
A One Health approach to pan-valent morbillivirus vaccines
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1009929
PubMed Identifier: 34534263
Publication URI: http://europepmc.org/abstract/MED/34534263
Type: Journal Article/Review
Volume: 17
Parent Publication: PLoS pathogens
Issue: 9
ISSN: 1553-7366